You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Bulk Pharmaceutical API Sources for NORLUTIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for NORLUTIN

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free N4128_SIGMA ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free N0449 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-002-507-131 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-11100 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A836053 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005267172 ⤷  Get Started Free
Mcule ⤷  Get Started Free MCULE-9156628994 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Norlutin

Last updated: August 2, 2025

Introduction

Norlutin, marketed under various brand names, is a synthetic progestin used primarily in hormone therapy, contraception, and management of menstrual disorders. The active pharmaceutical ingredient (API) in Norlutin is norethisterone (norethindrone), a potent progestogen with estrogenic and anti-estrogenic properties. The sourcing of high-quality, reliable, and compliant API suppliers is crucial for pharmaceutical manufacturers aiming to produce effective and safe Norlutin formulations. This article offers an in-depth review of global API suppliers specializing in norethisterone, emphasizing their manufacturing competencies, regulatory standing, and market positioning.

Overview of Norethisterone as an API

Norethisterone is synthesized through complex chemical processes involving steroid precursor molecules. Its manufacturing demands rigorous control over purity, stereochemistry, and efficacy, aligning with industry standards such as USP, EP, and ICH guidelines. Given its critical role in hormone therapy, sourcing from reputable suppliers ensures compliance, consistent batch quality, and regulatory approval.

Leading Global API Suppliers for Norethisterone

1. Bharat Biotech (India)

Bharat Biotech is a prominent Indian pharmaceutical company with robust capabilities in steroid synthesis. It manufactures norethisterone API conforming to international quality standards, focusing on cost-effective bulk production to serve both domestic and export markets. The company boasts WHO-GMP certification and adheres to stringent quality management practices, positioning it as a reliable source for pharmaceutical firms seeking stable supply chains.

2. Jubilant Pharmova (India)

Jubilant Pharmova has established itself as a leading API manufacturer with a significant portfolio in hormonal APIs, including norethisterone. With state-of-the-art synthesis facilities and strong R&D capabilities, Jubilant offers high-purity APIs compliant with global standards. The company's strategic focus on quality assurance and regulatory certifications (USFDA, EMA) make it a preferred choice for multinational pharmaceutical companies.

3. Shandong Xinhua Pharmaceutical (China)

As one of China's largest API producers, Shandong Xinhua Pharmaceutical supplies norethisterone to markets worldwide. The company invests heavily in advanced chemical synthesis technologies and maintains certifications such as GMP, ISO 9001, and ISO 14001. They emphasize high batch-to-batch consistency and comprehensive quality documentation, serving clients in North America, Europe, and Asia.

4. Hubei Yuancheng Pharmaceutical (China)

Specializing in complex steroid APIs, Hubei Yuancheng Pharmaceutical offers high-purity norethisterone suitable for pharmaceutical formulations. Their manufacturing facilities are compliant with multiple international standards, and the company maintains a strong pipeline for API synthesis development. Their strategic focus on quality upgradation positions them as a competitive supplier in the global API market.

5. Mitsubishi Tanabe Pharma (Japan)

Mitsubishi Tanabe Pharma, a leading Japanese pharmaceutical firm, supplies specialty APIs, including norethisterone, sourced from advanced chemical synthesis platforms. Their APIs meet rigorous quality specifications, including Japanese Pharmacopoeia standards, and cater primarily to markets emphasizing high-quality, innovative pharmaceutical products.

6. Sterling Biotech (India)

Sterling Biotech specializes in steroid intermediates and APIs, including norethisterone. Its manufacturing centers operate under strict GMP conditions, with comprehensive quality assurance protocols aligned with international standards. The company's focus on process innovation and cost competitiveness makes it a strategic partner for generic hormone API manufacturing.

Strategic Considerations in API Sourcing

Regulatory Compliance:
Selecting a supplier with established certifications (FDA, EMA, COS, PMDA) reduces regulatory hurdles and simplifies registration processes.

Quality Assurance and Control:
Suppliers should demonstrate robust quality management systems, validated manufacturing processes, and consistent batch quality.

Supply Chain Stability:
Long-term partnerships with suppliers demonstrating production scalability and reliable delivery schedules mitigate risks associated with supply shortages.

Pricing and Cost-Effectiveness:
While quality remains paramount, competitive pricing from established manufacturers in India and China makes them attractive for large-volume procurement.

Environmental and Ethical Standards:
Compliance with environmental regulations and sustainable manufacturing practices is increasingly critical, impacting procurement decisions.

Regional Variations in API Sourcing

India:
India remains the dominant source of norethisterone API, primarily due to its cost advantages, well-established chemical manufacturing infrastructure, and presence of GMP-certified factories. Companies like Jubilant and Sterling Biotech exemplify this trend.

China:
China’s API sector offers high-volume production capabilities, competitive pricing, and expanding regulatory compliance. Firms like Shandong Xinhua and Hubei Yuancheng are notable players.

Japan and Europe:
While fewer in number, Japanese and European suppliers focus on high-end, specialty APIs with stringent quality controls suitable for regulated markets demanding premium standards.

Challenges in API Sourcing for Norethisterone

  • Regulatory Divergences: Navigating varying standards across regions necessitates comprehensive validation and documentation.
  • Quality Fluctuations: Ensuring consistency amidst complex chemical synthesis processes requires ongoing audits and quality assurance.
  • Supply Disruptions: Political, economic, or logistical issues can impact supply stability, emphasizing the importance of diversified sourcing.
  • Environmental and Ethical Concerns: Increasing scrutiny on environmental impacts demands transparency and adherence to sustainable manufacturing practices.

Future Outlook

The API market for norethisterone is poised for growth, driven by increased hormone therapy demands and generic drug markets. Rising investments in biotech and chemical synthesis innovation present opportunities for suppliers to enhance purity, reduce costs, and develop environmentally friendly manufacturing processes. Moreover, regulatory harmonization efforts can streamline global sourcing, benefitting pharmaceutical manufacturers.

Conclusion

Sourcing high-quality norethisterone API remains vital for the pharmaceutical industry’s success in producing effective Norlutin formulations. Indian and Chinese manufacturers dominate the market, offering reliable, cost-effective options with broad regulatory recognition. However, strategic procurement must balance quality, regulatory compliance, supply stability, and environmental considerations. Building strong partnerships with reputable API suppliers enables manufacturers to mitigate risks and ensure a consistent supply chain, ultimately supporting the global demand for hormone therapies.


Key Takeaways

  • The majority of norethisterone API supply originates from India and China, leveraging their manufacturing scale and cost advantages.
  • Regulatory certifications such as WHO-GMP, USFDA, and EMA approval are vital indicators of supplier credibility.
  • Quality assurance procedures, including batch consistency and documentation, underpin reliable API sourcing.
  • Diversification of suppliers reduces supply chain risks amid geopolitical and logistical uncertainties.
  • Emerging trends favor environmentally sustainable and innovative manufacturing practices in the steroid API segment.

FAQs

1. Why is India a leading source for norethisterone API?
India offers a well-established steroid manufacturing infrastructure, cost-effective production, and numerous GMP-compliant facilities, making it a preferred sourcing destination.

2. What regulatory standards should I verify when sourcing norethisterone APIs?
Manufacturers should demonstrate compliance with standards such as USP, EP, WHO-GMP, USFDA, EMA, and other regional regulatory authorities to ensure quality and acceptance.

3. How can I assess the quality of a norethisterone API supplier?
Review their certification credentials, conduct audits, request batch quality data, and analyze their quality control protocols to evaluate reliability.

4. Are there any environmental concerns associated with sourcing norethisterone APIs from Chinese suppliers?
While some Chinese manufacturers have faced environmental scrutiny in the past, many now operate under stricter environmental regulations, and transparency varies; due diligence is essential.

5. What are the emerging trends in API sourcing for hormone APIs like norethisterone?
Increased focus on sustainable manufacturing, process innovation to improve purity and yield, and enhanced regulatory harmonization drive future sourcing strategies.


Sources

  1. [1] Market Line. "Global API Market Analysis," 2022.
  2. [2] U.S. Food and Drug Administration. "Guidelines for Steroid APIs," 2021.
  3. [3] Pharmaceutical Technology. "Steroid API Manufacturing Trends," 2022.
  4. [4] WHO. "Good Manufacturing Practices for Active Pharmaceutical Ingredients," 2019.
  5. [5] China Pharmaceutical Industry Development Report, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.